Cirena, Inc. is a biotechnology company focused on the chemical synthesis of long-chain RNA. The company’s proprietary platform enables efficient production of RNA strands extending to hundreds of nucleotides, addressing needs in gene editing, nucleic acid therapeutics, and advanced research applications. By enabling longer, precisely defined RNA sequences via chemical routes, Cirena supports customers developing next‑generation RNA tools and medicines.
Founded in 2024, Cirena serves pharmaceutical, biotech, and research organizations with custom RNA synthesis capabilities designed for scalability and reproducibility.